- US-listed companies
- DEXCOM INC
- Cash flow
DEXCOM INCDXCM
Market cap
$25.8B
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 4 | 7 | 7 | 8 | 11 | 15 | 16 | 29 | 49 | 67 | 102 | 156 | 186 | 218 |
| Stock-based compensation | 14 | 18 | 25 | 50 | 83 | 111 | 106 | 102 | 103 | 119 | 113 | 127 | 151 | 170 |
| Cash from operations | -30 | -33 | 2 | 24 | 49 | 56 | 92 | 123 | 315 | 476 | 443 | 670 | 749 | 990 |
| Capital expenditures | -8 | -9 | -8 | -16 | -33 | -56 | -66 | -67 | -180 | -199 | -389 | -365 | -237 | -359 |
| Cash from investing | -46 | 28 | 21 | -17 | -51 | -56 | -144 | -140 | -1,015 | -1,018 | -216 | -521 | -507 | -207 |
| Repurchases of common stock | - | - | - | - | - | - | - | 100 | - | - | - | 558 | 689 | 750 |
| Proceeds from issuance of term debt, net | - | 7 | - | - | - | - | - | - | - | - | - | - | - | - |
| Repayments of term debt | - | - | 0 | 2 | 2 | 2 | - | - | - | - | - | - | - | - |
| Cash from financing | 74 | 10 | 12 | 22 | 17 | 8 | 399 | 710 | 11 | 912 | 10 | -552 | -319 | -735 |
| Free cash flow | ||||||||||||||
| FCF margin (%) |